Skip to content
OpenAI
-
OpenAI collaborates with Novo Nordisk to accelerate drug discovery through advanced AI technology
The collaboration will enhance the company’s ability to analyze complex datasets, identify promising drug candidates, and significantly reduce the time required to bring medications to patients.